{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:12:18Z","timestamp":1757621538340,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.urolonc.2025.06.008","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:16:26Z","timestamp":1751958986000},"page":"596.e1-596.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor profiling of advanced urothelial carcinoma: Comparative analysis based on social determinants of health"],"prefix":"10.1016","volume":"43","author":[{"given":"Lacey J.","family":"Hart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenny","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Ruzdija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Bertolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irasema Concepcion","family":"Paster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo J.","family":"Estrada-Mendizabal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Manuel","family":"Guillen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Recio-Boiles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2603-0382","authenticated-orcid":false,"given":"Juan","family":"Chipollini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.06.008_bib0001","unstructured":"SEER: Surveillance, Epidemiology, and End Results. National Cancer Institute Web site. www.seer.cancer.gov. Accessed January 2, 2025."},{"issue":"10","key":"10.1016\/j.urolonc.2025.06.008_bib0002","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/iju.13376","article-title":"Epidemiology of urothelial carcinoma","volume":"24","author":"Miyazaki","year":"2017","journal-title":"Int J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.06.008_bib0003","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cncr.23567","article-title":"The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study","volume":"113","author":"Byers","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2025.06.008_bib0004","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bju.15629","article-title":"Disparity of race reporting in US Food and Drug Administration drug approvals for urinary system cancers from 2006 to 2021","volume":"129","author":"Glover","year":"2022","journal-title":"BJU Int"},{"issue":"10","key":"10.1016\/j.urolonc.2025.06.008_bib0005","doi-asserted-by":"crossref","first-page":"e910","DOI":"10.1093\/oncolo\/oyad120","article-title":"Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry","volume":"28","author":"Peak","year":"2023","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.urolonc.2025.06.008_bib0006","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/MLR.0000000000001624","article-title":"Race, Ethnicity, Neighborhood Characteristics, and In-Hospital Coronavirus Disease-2019 Mortality","volume":"59","author":"Hu","year":"2021","journal-title":"Med Care"},{"issue":"26","key":"10.1016\/j.urolonc.2025.06.008_bib0007","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas","volume":"378","author":"Kind","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2025.06.008_bib0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.socscimed.2016.08.047","article-title":"Research on neighborhood effects on health in the United States: A systematic review of study characteristics","volume":"168","author":"Arcaya","year":"2016","journal-title":"Soc Sci Med"},{"issue":"12","key":"10.1016\/j.urolonc.2025.06.008_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.39593","article-title":"Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers","volume":"4","author":"Cheng","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.urolonc.2025.06.008_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/AIA.0000000000000389","article-title":"Geospatial analysis of patients\u2019 social determinants of health for health systems science and disparity research","volume":"61","author":"Pearson","year":"2023","journal-title":"Int Anesthesiol Clin"},{"issue":"5","key":"10.1016\/j.urolonc.2025.06.008_bib0011","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.mou.0000174965.26439.d1","article-title":"Impact of socioeconomic status on bladder cancer outcome","volume":"15","author":"Shackley","year":"2005","journal-title":"Curr Opin Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.06.008_bib0012","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1464-410X.2004.04997.x","article-title":"West Midlands Urological Research Group. Socio-economic deprivation and survival in bladder cancer","volume":"94","author":"Begum","year":"2004","journal-title":"BJU Int"},{"issue":"7","key":"10.1016\/j.urolonc.2025.06.008_bib0013","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.bjc.6601696","article-title":"Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001","volume":"90","author":"Coleman","year":"2004","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.urolonc.2025.06.008_bib0014","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2105\/AJPH.93.7.1137","article-title":"Area deprivation and widening inequalities in US mortality, 1969-1998","volume":"93","author":"Singh","year":"2003","journal-title":"Am J Public Health"},{"issue":"12","key":"10.1016\/j.urolonc.2025.06.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.39593","article-title":"Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers","volume":"4","author":"Cheng","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"26","key":"10.1016\/j.urolonc.2025.06.008_bib0016","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible\u2014The neighborhood Atlas","volume":"378","author":"Kind","year":"2018","journal-title":"New Eng J Med"},{"issue":"1","key":"10.1016\/j.urolonc.2025.06.008_bib0017","doi-asserted-by":"crossref","first-page":"106","DOI":"10.32481\/djph.2024.03.14","article-title":"Mapping health disparities:: leveraging area-based deprivation indices for targeted chronic disease intervention","volume":"10","author":"Dow","year":"2024","journal-title":"Dela J Public Health"},{"key":"10.1016\/j.urolonc.2025.06.008_bib0018","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.urology.2023.02.045","article-title":"Insurance Type and Area Deprivation Are Associated With Worse Overall Mortality for Patients With Muscle-invasive Bladder Cancer","volume":"177","author":"Miller","year":"2023","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2025.06.008_bib0019","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.urology.2021.10.048","article-title":"Neighborhood Socioeconomic Disadvantage Associated With Increased 90-Day Mortality Following Radical Cystectomy","volume":"163","author":"Knorr","year":"2022","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.urolonc.2025.06.008_bib0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.urolonc.2025.06.008_bib0021","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.urolonc.2025.06.008_bib0022","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/hmg\/6.1.105","article-title":"Cancer risk associated with germline DNA mismatch repair gene mutations","volume":"6","author":"Dunlop","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.urolonc.2025.06.008_bib0023","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1158\/0008-5472.CAN-20-3991","article-title":"Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.urolonc.2025.06.008_bib0024","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajhg.2023.12.010","article-title":"A comprehensive analysis of clinical and polygenic germline influences on somatic mutational burden","volume":"111","author":"Taraszka","year":"2024","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.urolonc.2025.06.008_bib0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrc3497","article-title":"How ageing processes influence cancer","volume":"13","author":"De Magalh\u00e3es","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"10.1016\/j.urolonc.2025.06.008_bib0026","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1158\/0008-5472.CAN-18-0362","article-title":"Sex Differences in Cancer Driver Genes and Biomarkers","volume":"78","author":"Li","year":"2018","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.urolonc.2025.06.008_bib0027","first-page":"1389","article-title":"p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer","volume":"143","author":"Esrig","year":"1993","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.06.008_bib0028","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jnci\/85.1.53","article-title":"Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression","volume":"85","author":"Sarkis","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"7492","key":"10.1016\/j.urolonc.2025.06.008_bib0029","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.urolonc.2025.06.008_bib0030","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.eururo.2017.06.022","article-title":"Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma: A Step Closer to Clinical Translation?","volume":"72","author":"Rentsch","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.06.008_bib0031","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fonc.2015.00249","article-title":"Mutant p53: multiple mechanisms define biologic activity in cancer","volume":"5","author":"Kim","year":"2015","journal-title":"Front Oncol"},{"issue":"14","key":"10.1016\/j.urolonc.2025.06.008_bib0032","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1073\/pnas.122612899","article-title":"Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer","volume":"99","author":"Smith","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"47","key":"10.1016\/j.urolonc.2025.06.008_bib0033","doi-asserted-by":"crossref","first-page":"28514","DOI":"10.18632\/oncotarget.25530","article-title":"Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells","volume":"9","author":"Pandey","year":"2018","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.urolonc.2025.06.008_bib0034","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1158\/1055-9965.EPI-20-1555","article-title":"The Association between Polluted Neighborhoods and TP53-Mutated Non-Small Cell Lung Cancer","volume":"30","author":"Erhunmwunsee","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.urolonc.2025.06.008_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057361","article-title":"Household income is associated with the p53 mutation frequency in human breast tumors","volume":"8","author":"Starks","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.urolonc.2025.06.008_bib0036","doi-asserted-by":"crossref","first-page":"12438","DOI":"10.1002\/cam4.5953","article-title":"TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors","volume":"12","author":"Kim","year":"2023","journal-title":"Cancer Med"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392500242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392500242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:27:01Z","timestamp":1757338021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814392500242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S107814392500242X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.06.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor profiling of advanced urothelial carcinoma: Comparative analysis based on social determinants of health","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}